ClinicalTrials.govpublic full text
Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI
leukemia, leukemia, myeloid, leukemia, myelogenous, chronic, bcr-abl positive, philadelphia chromosome, hematologic diseases, radotinib, cml-cp, ap, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 917258
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.